Presentation of the Novel Study Design for the Phase 2 Expansion Study of ²¹²Pb-ADVC001 in Metastatic Prostate Cancer: The TheraPb Trial

27 February 2026March 2nd, 20261 min read

Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2026 on February 26, 2026

Presentation of the Novel Study Design for the Phase 2 Expansion Study of 212Pb-ADVC001 in Metastatic Prostate Cancer: The TheraPb Trial